"
Team:INSA-Lyon/Safety/Ethics
From 2010.igem.org
| Line 25: | Line 25: | ||
<div id="corps2"> | <div id="corps2"> | ||
| - | <h3> | + | <h3>Yesterday , Today and Tomorrow: An ethic future for SynBio ?</h3> |
| - | <br><p> | + | <br><p>The iGEM competition is an important showcase for the emergence of Synthetic biology, as well for scientist and non-scientist people. But, as a new unknown activity, especially a scientific one, SynBio brings interrogations: Is it dangerous? Are there some risks? How can it help our future? What are the challenges? <br> |
</p> | </p> | ||
| + | <br><h4><p style="text-indent:50px">Definition and description</h4> | ||
| + | </p> | ||
| + | <br> | ||
| + | <p>1974. In one sentence, the polish geneticist, <b>Waclaw Szybalski</b>, laid the foundations of the <em>Synthetic Biology</em>. Following the development of biology molecular and the discover of the enzyme of restriction, he thought that one day, it would be possible to build some new genomes, or parts of genomes. | ||
| + | Nowadays, <b>Hugh Whittall</b>, Director of the Nuffield Council on Bioethics, describes Synthetic Biology as <em>“the construction of novel biological networks/organisms with bespoke properties, using standardized biological parts that code for known functions”</em>. These parts can be extracting from existing organisms or be the results of a chemical synthesis after an artificial design. | ||
| + | </p> | ||
| + | <br> | ||
| + | <p style="text-indent:0px">The SynBio can be divided in two approaches: <em>top-down</em> and <em>Bottom-up</em>. The first one consists in starting from a whole organism, and then reducing its genome until it can only provide a specific function. The second one is the opposite: you create an organism just with biobricks (system developed by the MIT). You just add to the organism’s genome the genes that bring it the function of interest.</p> | ||
| + | <br> | ||
| + | <p> Three methods have been developed in this frame: minimal genome, artificial cells and synthetic biomolecules.<br> | ||
| + | <br> Table 1 <br> | ||
| + | <br> The development of synthetic biology is closely related to the development of IT and nanotechnology, as we can see in this schema: <br> | ||
| + | <br> Schema 1<br> | ||
| + | <br>It is obvious that without IT, there is no gene bank, no international access to information, which are the two main skills that increased the speed of progress in SynBio… </p> | ||
| + | <p style="text-indent:0px"> One of the innovations in SynBio is the multidisciplinary workforce. Because of the large aspects of application and the implication in the creation of an artificial life, SynBio workforce needs biologists, engineers, chemists, IT specialists, social, ethical and economic experts. This is an important asset that proves the impact that SynBio can have on the scientific word. But this underlines that creating life and controlling it is a huge and difficult power that needs the contribution of all the scientists’ communities. The domains of application are almost unlimited, because the objective is to create synthetic life, with various aims. | ||
| + | </p> | ||
| + | |||
</div> | </div> | ||
Revision as of 13:42, 21 October 2010
Yesterday , Today and Tomorrow: An ethic future for SynBio ?
The iGEM competition is an important showcase for the emergence of Synthetic biology, as well for scientist and non-scientist people. But, as a new unknown activity, especially a scientific one, SynBio brings interrogations: Is it dangerous? Are there some risks? How can it help our future? What are the challenges?
Definition and description
1974. In one sentence, the polish geneticist, Waclaw Szybalski, laid the foundations of the Synthetic Biology. Following the development of biology molecular and the discover of the enzyme of restriction, he thought that one day, it would be possible to build some new genomes, or parts of genomes. Nowadays, Hugh Whittall, Director of the Nuffield Council on Bioethics, describes Synthetic Biology as “the construction of novel biological networks/organisms with bespoke properties, using standardized biological parts that code for known functions”. These parts can be extracting from existing organisms or be the results of a chemical synthesis after an artificial design.
The SynBio can be divided in two approaches: top-down and Bottom-up. The first one consists in starting from a whole organism, and then reducing its genome until it can only provide a specific function. The second one is the opposite: you create an organism just with biobricks (system developed by the MIT). You just add to the organism’s genome the genes that bring it the function of interest.
Three methods have been developed in this frame: minimal genome, artificial cells and synthetic biomolecules.
Table 1
The development of synthetic biology is closely related to the development of IT and nanotechnology, as we can see in this schema:
Schema 1
It is obvious that without IT, there is no gene bank, no international access to information, which are the two main skills that increased the speed of progress in SynBio…
One of the innovations in SynBio is the multidisciplinary workforce. Because of the large aspects of application and the implication in the creation of an artificial life, SynBio workforce needs biologists, engineers, chemists, IT specialists, social, ethical and economic experts. This is an important asset that proves the impact that SynBio can have on the scientific word. But this underlines that creating life and controlling it is a huge and difficult power that needs the contribution of all the scientists’ communities. The domains of application are almost unlimited, because the objective is to create synthetic life, with various aims.
